We are live on ! Find out more
FLGT icon

Fulgent Genetics

299 hedge funds and large institutions have $1.13B invested in Fulgent Genetics in 2021 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 106 increasing their positions, 76 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 28

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

39% more repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 76

12% more funds holding

Funds holding: 268299 (+31)

10% more capital invested

Capital invested by funds: $1.02B → $1.13B (+$105M)

0.86% less ownership

Funds ownership: 38.56%37.7% (-0.86%)

5% less call options, than puts

Call options by funds: $60.4M | Put options by funds: $63.9M

Holders
299
Holders Change
+31
Holders Change %
+11.57%
% of All Funds
4.6%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
62
Increased
106
Reduced
76
Closed
28
Calls
$60.4M
Puts
$63.9M
Net Calls
-$3.44M
Net Calls Change
+$939K
Name Holding Trade Value Shares
Change
Change in
Stake
Canada Pension Plan Investment Board
176
Canada Pension Plan Investment Board
Ontario, Canada
$300K +$208K +2,363 +384%
VFM
177
Vivid Financial Management
California
$299K -$139K -1,581 -35%
ECM
178
Everence Capital Management
Indiana
$294K
QT
179
Quantamental Technologies
New York
$282K +$246K +2,803 New
SAM
180
Shell Asset Management
Netherlands
$279K +$1.14K +13 +0.5%
Millennium Management
181
Millennium Management
New York
$275K -$598K -6,803 -71%
APA
182
American Portfolios Advisors
New York
$272K +$28.3K +322 +14%
SCA
183
Snowden Capital Advisors
New York
$266K -$117K -1,330 -33%
MOACM
184
Mutual of America Capital Management
New York
$266K +$8K +91 +4%
CC
185
Commons Capital
Massachusetts
$262K +$229K +2,600 New
TC
186
TownSquare Capital
Utah
$260K +$11.7K +133 +5%
SSA
187
Schonfeld Strategic Advisors
New York
$257K +$225K +2,559 New
IC
188
IEQ Capital
California
$252K +$220K +2,507 New
FIM
189
Freedom Investment Management
Connecticut
$250K +$219K +2,489 New
JMPWA
190
JP Morgan Private Wealth Advisors
California
$247K +$439 +5 +0.2%
TI
191
Trexquant Investment
Connecticut
$247K +$216K +2,460 New
BC
192
BIT Capital
Germany
$244K
SO
193
STRS Ohio
Ohio
$231K +$79.1K +900 +64%
CAPTRUST Financial Advisors
194
CAPTRUST Financial Advisors
North Carolina
$202K -$28.5K -324 -14%
AWM
195
Accel Wealth Management
Iowa
$201K
Carson Wealth (CWM LLC)
196
Carson Wealth (CWM LLC)
Nebraska
$197K +$172K +1,954 New
DCM
197
Dupont Capital Management
Delaware
$195K -$68.1K -775 -29%
Simplex Trading
198
Simplex Trading
Illinois
$187K +$25.5K +290 +18%
SPIA
199
Steward Partners Investment Advisory
New York
$179K
National Bank of Canada
200
National Bank of Canada
Quebec, Canada
$172K +$151K +1,713 New

FLGT Hedge Fund Activity: Q4 2021 in Review

299 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q4 2021, worth a combined $1.13B — up 10% from $1.02B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new FLGT positions and 28 closed out — a net gain of 34 holders — while 106 added to existing stakes and 76 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $22.7M. The largest seller was JP Morgan Chase, cutting an estimated $34.7M.

  • 299 institutional investors held Fulgent Genetics (FLGT) as of Q4 2021, up from 268 in Q3 2021.
  • Funds reported $1.13B of Fulgent Genetics stock for Q4 2021, up 10% quarter-over-quarter.
  • 62 funds opened new Fulgent Genetics positions in Q4 2021 and 28 closed out, a net change of +34 holders.
  • The largest Fulgent Genetics buyer in Q4 2021 was Skandinaviska Enskilda Banken (SEB), an estimated $22.7M added.
  • The largest Fulgent Genetics seller in Q4 2021 was JP Morgan Chase, an estimated $34.7M sold.

Based on aggregated 13F filings for Q4 2021.